CompletedNot Applicable

Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women

Egypt160 participantsStarted 2021-01-01

Plain-language summary

Placenta praevia is associated with an increased risk of preterm delivery (PTD) especially if associated with bleeding and uterine contractions . In this study we will determine the effect of Progesterone in preventing a second attack of antepartum haemorrhage in pregnant women diagnosed with placenta previa

Who can participate

Age range24 Weeks – 34 Weeks

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * o Women diagnosed as placenta previa. * Women aged 20-40 years, who were pregnant in a single foetus * Gestational age ranging between 24 and 34 weeks * Patient had attack of Antepartum Haemorrhage or history of Antepartum Haemorrhage Exclusion Criteria: * o History of previous PTD * Polyhydramnios * Severe attack of bleeding requiring an immediate intervention * Intrauterine foetal death

What they're measuring

patient with past history of antepartum haemorrhage will not have a secondary attack

Timeframe: 2 weeks

Trial details

NCT IDNCT04725929

SponsorNourhan Ashraf ElSherbiny

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-06-01

View on ClinicalTrials.gov More Placenta Previa trials